Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | CA9 | Q16790 | 9/20 | 0.56 |
| ▸ | CA2 | P00918 | 4/20 | 0.56 |
| ▸ | ELANE | P08246 | 3/20 | 0.55 |
| ▸ | CTSG | P08311 | 1/20 | 0.55 |
| ▸ | CEL | P19835 | 1/20 | 0.55 |
| ▸ | CA12 | O43570 | 10/20 | 0.53 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | DRD2 | P14416 | 1/20 | 0.47 |
| ▸ | DRD4 | P21917 | 1/20 | 0.47 |
| ▸ | DRD5 | P21918 | 1/20 | 0.47 |
| ▸ | DRD3 | P35462 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30367636 | 1.00 | HPGD (0.58) | HPGDLMNACA9CA2ELANE | |
| Hydrogen Sulfide SCHEMBL29165723 | 0.98 | HPGD (0.57) | HPGDLMNACA9CA2ELANE | |
| SCHEMBL11094946 | 0.86 | CA12 (0.57) | HPGDLMNACA9CA2ELANE | |
| SCHEMBL6789680 | 0.82 | CA12 (0.54) | HPGDLMNACA9CA2ELANE | |
| SCHEMBL29019945 | 0.81 | CA9 (0.44) | HPGDLMNACA9CA2ELANE | |
| SCHEMBL27582170 | 0.81 | HPGD (0.44) | HPGDLMNACA9CA2ELANE | |
| SCHEMBL6788104 | 0.80 | NPC1 (0.53) | HPGDLMNACA9CA2ELANE | |
| SCHEMBL21933495 | 0.79 | LMNA (0.49) | HPGDLMNACA9CA2ELANE | |
| SCHEMBL28096156 | 0.79 | HPGD (0.43) | HPGDLMNACA9CA2ELANE | |
| SCHEMBL24205860 | 0.78 | CYP1A2 (0.44) | HPGDLMNACA9CA2ELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1274781-B1 | POLYCARBONATE COMPOSITION RESISTANT TO GAMMA RADIATION | BAYER AG (US) | 2004-12-15 | — | — | EP | claimed |
| US-6197854-B1 | Polycarbonate composition resistant to gamma radiation | BAYER CORPORATION | 2001-03-06 | — | — | US | claimed |
| EP-0742260-B1 | (Co)polycarbonates stabilized against gamma-rays | BAYER AG (DE) | 2000-07-05 | — | — | EP | claimed |
| US-5684062-A | MOLDING MATERIALS WITH STABILIZATION TO RADIATION | BAYER AG (DE) | 1997-11-04 | — | — | US | claimed |
| US-20250188046-A1 | ULTRAFAST FLOW SYNTHESIS OF FUNCTIONALIZED SULFONYL FLUORIDES AND SUBSEQUENT SUFEX CONNECTIONS VIA LITHIATED CHEMISTRY | POSTECH Research and Business Development Foundation (KR) | 2025-06-12 | — | — | US | disclosed |
| CN-106008391-A | Preparation method of 2-phenyl-1,1-dioxo-1,2-benzisothiazole-3(2H)-one | 东华大学 | 2016-10-12 | — | — | CN | disclosed |
| CN-106008391-A | Preparation method of 2-phenyl-1,1-dioxo-1,2-benzisothiazole-3(2H)-one | 东华大学 | 2016-10-12 | — | — | CN | disclosed |
| US-20150272939-A1 | Identification of Small Molecule Inhibitors of Jumonji AT-Rich Interactive Domain 1A (JARID1A) and 1B (JARID1B) Histone Demethylase | YALE UNIVERSITY (US) | 2015-10-01 | — | — | US | disclosed |
| US-20150272939-A1 | Identification of Small Molecule Inhibitors of Jumonji AT-Rich Interactive Domain 1A (JARID1A) and 1B (JARID1B) Histone Demethylase | YALE UNIVERSITY (US) | 2015-10-01 | — | — | US | disclosed |
| US-5684062-A | MOLDING MATERIALS WITH STABILIZATION TO RADIATION | BAYER AG (DE) | 1997-11-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250188046-A1 | ULTRAFAST FLOW SYNTHESIS OF FUNCTIONALIZED SULFONYL FLUORIDES AND SUBSEQUENT SUFEX CONNECTIONS VIA LITHIATED CHEMISTRY | FGFR4, STS, FGFR1 | HPGD 4811/4885LMNA 3753/4885CA9 1208/4885 |
| US-20150272939-A1 | Identification of Small Molecule Inhibitors of Jumonji AT-Rich Interactive Domain 1A (JARID1A) and 1B (JARID1B) Histone Demethylase | KDM1B, KDM1A, JMJD1C | HPGD 2498/4885LMNA 3900/4885CA9 2616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.